Mitchell Mudra, BA, Nacide Ercan-Fang, MD, Litao Zhong, MD, PHD, Julie Furne, BS1 and Michael Levitt, MD
1.Minneapolis VA Medical Center Research Service, Minneapolis, Minnesota
2.Department of Medicine, University of Minnesota, Minneapolis, Minnesota
3.NatureGen, Inc., San Diego, California
1. Address correspondence and reprint requests to Michael Levitt, MD, Research Office, Minneapolis VAMC, 1 Veterans Dr., Minneapolis, MN 55414. E-mail: firstname.lastname@example.org
In Asia, type 2 diabetes is treated with mulberry leaf. Studies supporting this usage include the demonstration that mulberry leaf 1) reduced blood glucose in normal rats (1) and rats with diabetes induced by streptozotocin (2) or alloxan (3), 2) reduced fasting blood glucose and A1C concentrations in 12 subjects with type 2 diabetes (4), and 3) relative to glybenclamide therapy, reduced fasting blood glucose, serum lipids, and lipid peroxidation indicators in subjects with type 2 diabetes (5). In the present study, we determined whether co-ingestion of mulberry extract with 75 g sucrose influenced the blood glucose response and sucrose absorption of type 2 diabetic and control subjects.